AstraZeneca in merger talks with BMS; combined market cap around $400 billion

1. 1The Financial Times reported that AstraZeneca (AZN) has been discussing a potential merger with US competitor Bristol-Myers Squibb (BMY).
2. 2The combined market cap would be roughly $400 billion, making it the world's fourth-largest pharma company, with AstraZeneca at about $264 billion and BMS at about $133 billion.
3. 3Following the report, AstraZeneca shares fell 6–7% while BMS rose, and neither company has issued an official confirmation.

Source Moby +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →